Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Endocrine Neoplasia Type 1 1

Interventions

Magnetic Resonance Spectroscopy 17 Specimen Handling 13 lutetium Lu 177 dotatate 7 gallium Ga 68 dotatate 7 Cisplatin 7 cabozantinib 6 pazopanib 5 Sorafenib 5 Fluorodeoxyglucose F18 5 Everolimus 5 Etoposide 4 romidepsin 3 olaparib 3 fluorodopa F 18 3 cixutumumab 3 X-Rays 3 Temozolomide 3 Sunitinib 3 Radiotherapy 3 Nivolumab 3 Ipilimumab 3 Iodine-131 3 CTLA-4 Antigen 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3 tipifarnib 2 belinostat 2 aldesleukin 2 aflibercept 2 Vorinostat 2 Trastuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × testosterone enanthate × Endocrine × Clear all

NCT00493987 2010-05-13

5aR

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Completed

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡